Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acquired Thrombotic Thrombocytopenic Purpura”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Not applicableStudy completedNCT05876221
What this trial is testing

Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
University of Cologne 223
Post-approval studies (Phase 4)UnknownNCT05135442
What this trial is testing

Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04021173
What this trial is testing

A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Lee's Pharmaceutical Limited 74
Testing effectiveness (Phase 2)Study completedNCT01554514
What this trial is testing

Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Washington University School of Medicine 19
Testing effectiveness (Phase 2)Study completedNCT00907751
What this trial is testing

Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Assistance Publique - Hôpitaux de Paris 12
Not applicableStudy completedNCT04845113
What this trial is testing

Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies in Children

Who this might be right for
Idiopathic Purpura
University Hospital, Montpellier 200
Not applicableLooking for participantsNCT06727669
What this trial is testing

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Who this might be right for
Immune ThrombocytopeniaThrombotic Thrombocytopenic PurpuraHemophilia A, Acquired+13 more
Peking University People's Hospital 3,000
Large-scale testing (Phase 3)Study completedNCT02553317
What this trial is testing

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Ablynx, a Sanofi company 145
Not applicableLooking for participantsNCT04985318
What this trial is testing

Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
University of Cologne 350
Not applicableActive Not RecruitingNCT05046717
What this trial is testing

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Fundación Española de Hematología y Hemoterapía 500
Not applicableEnrolling By InvitationNCT02422875
What this trial is testing

Comparative Autoantibody and Immunologic Cell Marker Study

Who this might be right for
Autoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases
Emory University 2,500
Testing effectiveness (Phase 2)Study completedNCT03922308
What this trial is testing

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Shire 28
Not applicableActive Not RecruitingNCT06928233
What this trial is testing

Association of TNFAIP3 With Immune-mediated TTP

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 400
Large-scale testing (Phase 3)Not Yet RecruitingNCT05568147
What this trial is testing

Aspirin for Prophylaxis of TTP

Who this might be right for
Thrombotic Thrombocytopenic Purpura
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Study completedNCT01151423
What this trial is testing

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Ablynx, a Sanofi company 75
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50
Not applicableUnknownNCT05262881
What this trial is testing

A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Catholic University of the Sacred Heart 50
Large-scale testing (Phase 3)Study completedNCT04074187
What this trial is testing

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Sanofi 21
Testing effectiveness (Phase 2)UnknownNCT04720261
What this trial is testing

Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
University Hospital, Rouen 125
Load More Results